Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 15, 2015 - Issue 1
Submit an article Journal homepage
1,038
Views
57
CrossRef citations to date
0
Altmetric
SPECIAL FOCUS: Alzheimer's Disease Therapy - Review

Advances in the therapy of Alzheimer’s disease: targeting amyloid beta and tau and perspectives for the future

Harald HampelAXA Research Fund and UPMC Chair, Paris, France;Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France
,
Lon S SchneiderKeck School of Medicine, University of Southern California, Los Angeles, CA, USA
,
Ezio GiacobiniDepartment of Internal Medicine, Rehabilitation and Geriatrics, University of Geneva Faculty of Medicine and Geneva University Hospitals, Geneva, Switzerland
,
Miia KivipeltoKarolinska Institutet Center for Alzheimer Research, Stockholm, Sweden;Department of Neurology, University of Eastern Finland, Kuopio, Finland;Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
,
Shireen SindiKarolinska Institutet Center for Alzheimer Research, Stockholm, Sweden;Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden
,
Bruno DuboisSorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, France
,
Karl BroichFederal Institute of Drugs and Medical Devices (BfArM), Bonn, Germany
,
Robert NisticòDepartment of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy;IRCSS Santa Lucia Foundation, Rome, Italy
,
Paul S AisenDepartment of Neurosciences, University of California, San Diego, CA, USA
&
Simone ListaAXA Research Fund and UPMC Chair, Paris, France;Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Institut de la Mémoire et de la Maladie d’Alzheimer (IM2A) and Institut du Cerveau et de la Moelle épinière (ICM), Département de Neurologie, Hôpital de la Pitié-Salpétrière, Paris, FranceCorrespondence[email protected]
 show all
Pages 83-105 | Published online: 24 Dec 2014

Citations (57)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Susana Cardoso, Raquel M. Seiça & Paula I. Moreira. (2017) Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease. Expert Review of Neurotherapeutics 17:1, pages 77-91.
Read now
Diane Stephenson. (2015) Alzheimer’s disease: current and future therapy. Expert Review of Neurotherapeutics 15:1, pages 1-2.
Read now

Articles from other publishers (55)

Michael Kunle Ajenikoko, Abayomi Oyeyemi Ajagbe, Oluwanisola Akanji Onigbinde, Akeem Ayodeji Okesina & Ahmad Adekilekun Tijani. (2023) Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction. IBRO Neuroscience Reports 14, pages 64-76.
Crossref
Eleonora Daini, Eleonora Vandini, Martina Bodria, Wenjie Liao, Carlo Baraldi, Valentina Secco, Alessandra Ottani, Michele Zoli, Daniela Giuliani & Antonietta Vilella. (2023) Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice. Frontiers in Immunology 13.
Crossref
Elena V. Mitroshina, Alexander M. Pakhomov, Mikhail I. Krivonosov, Roman S. Yarkov, Maria S. Gavrish, Alexey V. Shkirin, Mikhail V. Ivanchenko & Maria V. Vedunova. (2022) Novel Algorithm of Network Calcium Dynamics Analysis for Studying the Role of Astrocytes in Neuronal Activity in Alzheimer’s Disease Models. International Journal of Molecular Sciences 23:24, pages 15928.
Crossref
Na Li, Xiaoxiang Gao, Lingjun Zheng, Qihui Huang, Feng Zeng, Hongbin Chen, Mohamed A. Farag & Chao Zhao. (2022) Advances in fucoxanthin chemistry and management of neurodegenerative diseases. Phytomedicine 105, pages 154352.
Crossref
Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, Umar Manzoor, Mohd Azhardin Ganayee, Aadil Qadir Bhat, Ghulam Hassan Dar, Badrah S. Alghamdi, Anwar M. Hashem, Mohd Jamal Dar, Gulam Md. Ashraf & Tariq Maqbool. (2022) Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease. Frontiers in Aging Neuroscience 14.
Crossref
Bhaskar Jyoti Dutta, Shamsher Singh, Sanket Seksaria, Ghanshyam Das Gupta, Surendra H. Bodakhe & Amrita Singh. (2022) Potential role of IP3/Ca2+ signaling and phosphodiesterases: Relevance to neurodegeneration in Alzheimer’s disease and possible therapeutic strategies. Biochemical Pharmacology 201, pages 115071.
Crossref
Natalia V. Zakharova, Alexey S. Kononikhin, Maria I. Indeykina, Anna E. Bugrova, Polina Strelnikova, Stanislav Pekov, Sergey A. Kozin, Igor A. Popov, Vladimir Mitkevich, Alexander A. Makarov & Evgeny N. Nikolaev. (2022) Mass spectrometric studies of the variety of beta‐amyloid proteoforms in Alzheimer's disease. Mass Spectrometry Reviews.
Crossref
Lucie Cahlíková, Rudolf Vrabec, Filip Pidaný, Rozálie Peřinová, Negar Maafi, Abdullah Al Mamun, Aneta Ritomská, Viriyanata Wijaya & Gerald Blunden. (2021) Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease. Molecules 26:17, pages 5240.
Crossref
Mei-Hong Lu, Wen-Li Ji, Hong Chen, Yan-Yun Sun, Xiu-Yun Zhao, Fen Wang, Yi Shi, Yan-Ning Hu, Bo-Xiang Liu, Jing-wen Wu, De-En Xu, Jia-Wei Zheng, Chun-Feng Liu & Quan-Hong Ma. (2021) Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model. Frontiers in Aging Neuroscience 13.
Crossref
Yosra Nadhimi & Daniel A. Llano. (2021) Does hearing loss lead to dementia? A review of the literature. Hearing Research 402, pages 108038.
Crossref
Lei Huang, Yang Zhang, Yongwei Wang & Yajia Lan. (2021) Relationship Between Chronic Noise Exposure, Cognitive Impairment, and Degenerative Dementia: Update on the Experimental and Epidemiological Evidence and Prospects for Further Research. Journal of Alzheimer's Disease 79:4, pages 1409-1427.
Crossref
Hariharakrishnan Chidambaram, Rashmi Das & Subashchandrabose Chinnathambi. (2020) Interaction of Tau with the chemokine receptor, CX3CR1 and its effect on microglial activation, migration and proliferation. Cell & Bioscience 10:1.
Crossref
Andrea González, Leonardo Guzmán-Martínez & Ricardo B. Maccioni. (2020) Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer’s Disease. Journal of Alzheimer's Disease 77:2, pages 877-883.
Crossref
Ashim Paul, Moran Frenkel-Pinter, Daniela Escobar Alvarez, Giulia Milordini, Ehud Gazit, Elsa Zacco & Daniel Segal. (2020) Tryptophan-galactosylamine conjugates inhibit and disaggregate amyloid fibrils of Aβ42 and hIAPP peptides while reducing their toxicity. Communications Biology 3:1.
Crossref
Elena V. Mitroshina, Roman S. Yarkov, Tatiana A. Mishchenko, Victoria G. Krut’, Maria S. Gavrish, Ekaterina A. Epifanova, Alexey A. Babaev & Maria V. Vedunova. (2020) Brain-Derived Neurotrophic Factor (BDNF) Preserves the Functional Integrity of Neural Networks in the β-Amyloidopathy Model in vitro. Frontiers in Cell and Developmental Biology 8.
Crossref
Mei-Hong Lu, Xiu-Yun Zhao, De-En Xu, Ji-Bo Chen, Wen-Li Ji, Ze-Ping Huang, Ting-Ting Pan, Lu-Lu Xue, Fen Wang, Qi-Fa Li, Yue Zhang, Ting-Hua Wang, Yuchio Yanagawa, Chun-Feng Liu, Ru-Xiang Xu, Yi-Yuan Xia, Shao Li & Quan-Hong Ma. (2020) Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer’s Disease Model Mice. Journal of Alzheimer's Disease 75:1, pages 245-260.
Crossref
Chia-Hsiung Cheng, Kun-Ju Lin, Chien-Tai Hong, Dean Wu, Hung-Ming Chang, Cheng-Huan Liu, Ing-Tsung Hsiao, Chih-Ping Yang, Yu-Chuan Liu & Chaur-Jong Hu. (2019) Plasmon-Activated Water Reduces Amyloid Burden and Improves Memory in Animals with Alzheimer’s Disease. Scientific Reports 9:1.
Crossref
Alessandra Caruso, Ferdinando Nicoletti, Alessandra Gaetano & Sergio Scaccianoce. (2019) Risk Factors for Alzheimer’s Disease: Focus on Stress. Frontiers in Pharmacology 10.
Crossref
Lenka Hromadkova & Saak Victor Ovsepian. (2019) Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease. Journal of Immunology Research 2019, pages 1-11.
Crossref
Elliott J. Mufson, Scott E. Counts, Stephen D. Ginsberg, Laura Mahady, Sylvia E. Perez, Stephen M. Massa, Frank M. Longo & Milos D. Ikonomovic. (2019) Nerve Growth Factor Pathobiology During the Progression of Alzheimer’s Disease. Frontiers in Neuroscience 13.
Crossref
Eliška Kohelová, Rozálie Peřinová, Negar Maafi, Jan Korábečný, Daniela Hulcová, Jana Maříková, Tomáš Kučera, Loreto Martínez González, Martina Hrabinova, Katarina Vorčáková, Lucie Nováková, Angela De Simone, Radim Havelek & Lucie Cahlíková. (2019) Derivatives of the β-Crinane Amaryllidaceae Alkaloid Haemanthamine as Multi-Target Directed Ligands for Alzheimer’s Disease. Molecules 24:7, pages 1307.
Crossref
Mousa Alghazwi, Scott Smid, Ian Musgrave & Wei Zhang. (2019) In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation. Neurochemistry International 124, pages 215-224.
Crossref
Leonardo Guzmán-Martínez, José Pablo Tapia, Gonzalo A. Farías, Andrea González, Matías Estrella & Ricardo B. Maccioni. (2019) The Alz-tau Biomarker for Alzheimer’s Disease: Study in a Caucasian Population. Journal of Alzheimer's Disease 67:4, pages 1181-1186.
Crossref
Harald Hampel, Sid E. O’Bryant, José L. Molinuevo, Henrik Zetterberg, Colin L. Masters, Simone Lista, Steven J. Kiddle, Richard Batrla & Kaj Blennow. (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology 14:11, pages 639-652.
Crossref
Tengfei Guo, Juergen Dukart, Matthias Brendel, Axel Rominger, Timo Grimmer & Igor Yakushev. (2018) Rate of β‐amyloid accumulation varies with baseline amyloid burden: Implications for anti‐amyloid drug trials. Alzheimer's & Dementia 14:11, pages 1387-1396.
Crossref
Roopkumar Sangubotla & Jongsung Kim. (2018) Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer's disease. TrAC Trends in Analytical Chemistry 105, pages 240-250.
Crossref
Rita Gonçalves-Pereira, Margarida P. Pereira, Sofia G. Serra, Anne Loesche, René Csuk, Samuel Silvestre, Paulo J. Costa, M. Conceição Oliveira & Nuno M. Xavier. (2018) Furanosyl Nucleoside Analogues Embodying Triazole or Theobromine Units as Potential Lead Molecules for Alzheimer's Disease. European Journal of Organic Chemistry 2018:20-21, pages 2667-2681.
Crossref
Alessandra Caruso, Ferdinando Nicoletti, Dalila Mango, Amira Saidi, Rosamaria Orlando & Sergio Scaccianoce. (2018) Stress as risk factor for Alzheimer’s disease. Pharmacological Research 132, pages 130-134.
Crossref
Miren Ettcheto, Sonia Abad, Dmitry Petrov, Ignacio Pedrós, Oriol Busquets, Elena Sánchez-López, Gemma Casadesús, Carlos Beas-Zarate, Eva Carro, Carme Auladell, Jordi Olloquequi, Merce Pallàs, Jaume Folch & Antoni Camins. (2017) Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease. Molecular Neurobiology 55:6, pages 4885-4895.
Crossref
Stephen P. Arnerić, Volker D. Kern & Diane T. Stephenson. (2018) Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments. Biochemical Pharmacology 151, pages 291-306.
Crossref
Yi Su, Shaney Flores, Russ C. Hornbeck, Benjamin Speidel, Andrei G. Vlassenko, Brian A. Gordon, Robert A. Koeppe, William E. Klunk, Chengjie Xiong, John C. Morris & Tammie L.S. Benzinger. (2018) Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. NeuroImage: Clinical 19, pages 406-416.
Crossref
Lasse Pihlstrøm, Sarah Wiethoff & Henry Houlden. 2018. Neuropathology. Neuropathology 309 323 .
Yung-Chih Kuo & Rajendiran Rajesh. (2017) A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment. Journal of the Taiwan Institute of Chemical Engineers 77, pages 92-105.
Crossref
Lydia M Young, Alison E Ashcroft & Sheena E Radford. (2017) Small molecule probes of protein aggregation. Current Opinion in Chemical Biology 39, pages 90-99.
Crossref
Diana Pisa, Ruth Alonso, Ana M. Fernández-Fernández, Alberto Rábano & Luis Carrasco. (2017) Polymicrobial Infections In Brain Tissue From Alzheimer’s Disease Patients. Scientific Reports 7:1.
Crossref
Chiara Giacomelli, Simona Daniele & Claudia Martini. (2017) Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. Biochemical Pharmacology 131, pages 1-15.
Crossref
Tong Guo, Wendy Noble & Diane P. Hanger. (2017) Roles of tau protein in health and disease. Acta Neuropathologica 133:5, pages 665-704.
Crossref
Clifford R. JackJr.Jr., Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Val J. Lowe, David S. Knopman, Jeffrey L. Gunter, Matthew L. Senjem, David T. Jones, Kejal Kantarci, Mary M. Machulda, Michelle M. Mielke, Rosebud O. Roberts, Prashanthi Vemuri, Denise A. Reyes & Ronald C. Petersen. (2016) Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimer's & Dementia 13:3, pages 205-216.
Crossref
Howard Friel & Sally Frautschy. 2017. A Paradigm Shift to Prevent and Treat Alzheimer's Disease. A Paradigm Shift to Prevent and Treat Alzheimer's Disease 3 15 .
Razieh Hosseini, Fatemeh Moosavi, Hamid Rajaian, Tiago Silva, Diogo Magalhães e Silva, Pedro Soares, Luciano Saso, Najmeh Edraki, Ramin Miri, Fernanda Borges & Omidreza Firuzi. (2016) Discovery of neurotrophic agents based on hydroxycinnamic acid scaffold. Chemical Biology & Drug Design 88:6, pages 926-937.
Crossref
Diana Pisa, Ruth Alonso, Alberto Rábano, Michael N. Horst & Luis Carrasco. (2016) Fungal Enolase, β-Tubulin, and Chitin Are Detected in Brain Tissue from Alzheimer’s Disease Patients. Frontiers in Microbiology 7.
Crossref
Elliott J. Mufson, Milos D. Ikonomovic, Scott E. Counts, Sylvia E. Perez, Michael Malek-Ahmadi, Stephen W. Scheff & Stephen D. Ginsberg. (2016) Molecular and cellular pathophysiology of preclinical Alzheimer’s disease. Behavioural Brain Research 311, pages 54-69.
Crossref
Clifford R. JackJrJrDavid A. BennettKaj BlennowMaria C. CarrilloHoward H. FeldmanGiovanni B. FrisoniHarald HampelWilliam J. JagustKeith A. JohnsonDavid S. KnopmanRonald C. PetersenPhilip ScheltensReisa A. SperlingBruno Dubois. (2016) A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87:5, pages 539-547.
Crossref
Valérie Vingtdeux, Haitian Zhao, Pallavi Chandakkar, Christopher M Acker, Peter Davies & Philippe Marambaud. (2016) A Modification-Specific Peptide-Based immunization Approach Using CRM197 Carrier Protein: Development of a Selective Vaccine Against Pyroglutamate Aβ Peptides. Molecular Medicine 22:1, pages 841-849.
Crossref
Francesco Panza, Vincenzo Solfrizzi, Davide Seripa, Bruno P. Imbimbo, Madia Lozupone, Andrea Santamato, Chiara Zecca, Maria Rosaria Barulli, Antonello Bellomo, Alberto Pilotto, Antonio Daniele, Antonio Greco & Giancarlo Logroscino. (2016) Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease. BioMed Research International 2016, pages 1-15.
Crossref
M.E. Schmidt, D.C. Matthews & S. Staelens. 2016. Developing Therapeutics for Alzheimer's Disease. Developing Therapeutics for Alzheimer's Disease 523 563 .
O. G. Tatarnikova, M. A. Orlov & N. V. Bobkova. (2016) Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties. Biochemistry (Moscow) 80:13, pages 1800-1819.
Crossref
Jeffrey T. Apter, Kuntal Shastri & Katherine Pizano. (2015) Update on Disease-Modifying/Preventive Therapies in Alzheimer’s Disease. Current Geriatrics Reports 4:4, pages 312-317.
Crossref
Diana Pisa, Ruth Alonso, Alberto Rábano, Izaskun Rodal & Luis Carrasco. (2015) Different Brain Regions are Infected with Fungi in Alzheimer’s Disease. Scientific Reports 5:1.
Crossref
Jaspreet Kalra & Aamir Khan. (2015) Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease. European Journal of Pharmacology 764, pages 571-581.
Crossref
Guanglin Kuang, N. Arul Murugan, Yaoquan Tu, Agneta Nordberg & Hans Ågren. (2015) Investigation of the Binding Profiles of AZD2184 and Thioflavin T with Amyloid-β(1–42) Fibril by Molecular Docking and Molecular Dynamics Methods. The Journal of Physical Chemistry B 119:35, pages 11560-11567.
Crossref
Kurt A. Jellinger. (2015) Update on Alzheimer’s Disease. EMJ Neurology, pages 82-90.
Crossref
Lucie Cahlíková, Daniel I. Pérez, Šárka Štěpánková, Jakub Chlebek, Marcela Šafratová, Anna Hošt’álková & Lubomír Opletal. (2015) In Vitro Inhibitory Effects of 8- O -Demethylmaritidine and Undulatine on Acetylcholinesterase and Their Predicted Penetration across the Blood–Brain Barrier . Journal of Natural Products 78:6, pages 1189-1192.
Crossref
Ronald Melki. (2015) Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases. Journal of Parkinson's Disease 5:2, pages 217-227.
Crossref
Danica Stanimirovic & Kristin Kemmerich. (2015) Conquering the barriers: are antibody therapeutics feasible for CNS indications?. Future Neurology 10:2, pages 67-70.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.